D-0069-2022 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0069-2022 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Oct 12, 2021 and is designated Class III. Reason for recall: Failed Moisture Limits The recall status is terminated (terminated Aug 31, 2023). Affected quantity: 46,584 blister packs.

Recall details

Product Type
Drugs
Report Date
Nov 3, 2021
Initiation Date
Oct 12, 2021
Termination Date
Aug 31, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
46,584 blister packs

Product description

AllerClear D-24 hr, (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10/240mg), 15-count blister packs, Manufactured by: Ohm Laboratories Inc., 1385 Livingston Avenue, North Brunswick, NJ 08902, NDC 63981-724-15

Reason for recall

Failed Moisture Limits

Distribution pattern

Nationwide within the United States

Code information

AC09723, Exo, Date 11/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0069-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0069-2022. Report a data issue: hello@regdatalab.com.